About Us
Facilities
Quality
EHS
IP
Services & Solutions
Oligonucleotide Discovery
Oligonucleotide synthesis
Oligo-conjugate synthesis
Oligonucleotide CMC
API-Oligo
API-PMO
Drug Product
Analytical
CMC-Filing
Oligo Monomer & Ligand
Amidite synthesis
GalNAc synthesis
News
WuXi STA Forms Strategic Partnership with Coherent Biopharma
News: WuXi STA Opens New Drug Product Facility in Wuxi City Site
News: WuXi STA Starts Construction of New Site in Taixing China
Expansion Plan Annouced at DCAT Including Oligonucleotide
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers
Resource
Brochure: CRDMO platform for Oligonucleotide, Peptide and Complex Conjugate
Interview: TRENDS IN OLIGONUCLEOTIDE DRUG DEVELOPMENT - A VIRTUAL PANEL DISCUSSION
Oligonucleotide Drug Discovery
Oligonucleotide Drug Development (CMC)
Accelerating PPMO Development and Large-scale Manufacturing with Integrated Peptide
DNA G-Quadruplexes kilo-Grams Scale Production with Controlled Heavy Metal Strategy
Contact
Career